Nano X Imaging Ltd
$ 1.93
-6.76%
05 Jun - close price
- Market Cap 134,309,000 USD
- Current Price $ 1.93
- High / Low $ 2.06 / 1.90
- Stock P/E N/A
- Book Value 2.01
- EPS -1.16
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.20 %
- ROE -0.46 %
- 52 Week High 5.72
- 52 Week Low 1.59
About
Nano-X Imaging Ltd., a development-stage company, develops, produces and markets digital X-ray source technology for the medical imaging industry globally. The company is headquartered in Neve Ilan, Israel.
Analyst Target Price
$7.20
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-04-20 | 2025-12-31 | 2025-11-20 | 2025-08-12 | 2025-05-22 | 2025-03-31 | 2024-11-21 | 2024-08-20 | 2024-05-28 | 2024-03-14 | 2023-11-28 | 2023-08-17 |
| Reported EPS | -0.4977 | -0.17 | -0.15 | -0.17 | -0.15 | -0.17 | -0.15 | -0.14 | -0.21 | -0.18 | -0.37 | -0.31 |
| Estimated EPS | -0.14 | -0.15 | -0.17 | -0.15 | -0.15 | -0.15 | -0.15 | -0.15 | -0.26 | -0.3 | -0.3 | -0.26 |
| Surprise | -0.3577 | -0.02 | 0.02 | -0.02 | 0 | -0.02 | 0 | 0.01 | 0.05 | 0.12 | -0.07 | -0.05 |
| Surprise Percentage | -255.5% | -13.3333% | 11.7647% | -13.3333% | 0% | -13.3333% | 0% | 6.6667% | 19.2308% | 40% | -23.3333% | -19.2308% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: NNOX
2026-06-02 15:40:25
Nanox Imaging Ltd. has announced an exclusive distribution agreement with Top Med SAC for the deployment of its Nanox.ARC system in Peru. This agreement aims to expand access to advanced diagnostic imaging services in Peru, with an initial deployment of six Nanox.ARC systems under a capex model. Top Med will be responsible for regulatory approvals, marketing, installation, and support, leveraging its shared ownership with U.S.-based teleradiology provider TopRad.
2026-06-02 15:40:25
Nanox (NASDAQ: NNOX) has signed an exclusive distribution agreement with Top Med to deploy its Nanox.ARC imaging system and platform in Peru. The deal, structured as a capex model, initially plans for six Nanox.ARC systems following a pilot phase and regulatory approvals. This initiative aims to expand access to advanced and lower-cost 3D diagnostic imaging in Peru, addressing areas with uneven distribution of such services.
2026-05-26 11:00:09
NANO-X IMAGING LTD (NNOX) is expected to announce its Q1'26 earnings on May 27th. Analysts estimate revenue to be $4.54 million and earnings per share (EPS) at -$0.20. The article also provides a historical table of reported and estimated revenues and EPS, along with surprise percentages for previous quarters.
2026-05-21 15:45:00
Pomerantz LLP is investigating potential securities fraud claims against Nano-X Imaging Ltd. (NNOX) following a significant drop in its stock price. The investigation stems from Nano-X's Q4 2025 financial results, which reported a $33.4 million net loss due to a $17.5 million impairment charge at its Korean chip manufacturing facility and the announced departure of its CFO. Consequently, Nano-X's stock fell 24.39% on April 20, 2026.
2026-05-20 01:38:45
Pomerantz LLP is investigating potential securities fraud claims against Nano-X Imaging Ltd. following the company's report of a significant $33.4 million net loss in Q4 2025, largely due to a $17.5 million impairment charge related to restructuring its Korean chip facility. The investigation also stems from the resignation of CFO Ran Daniel. After these announcements, Nano-X's stock price experienced a substantial 24.39% drop, raising concerns among investors.
2026-05-15 10:40:17
Nano-X Imaging Ltd. has reported an amended passive investment disclosure (Schedule 13G/A), indicating that SK square Co., Ltd. and SK Square Americas, Inc. are no longer beneficial owners of over 5% of its ordinary shares. This "exit filing" updates a previous Schedule 13G from February 2022, with the reporting persons now holding 0.0% ownership as of the March 31, 2026 cover date.
